Specially, triple-negative breast cancer (TNBC), an aggressive subtype of breast cancer with poorest prognosis and lower survival, is refractory to current therapies duo to lack expression of estrogen receptor (ER), progesterone receptor (PR) and the overexpression of the HER2/neu receptor. The gene discussed is ESR1; the disease is breast cancer.